Advertisement
Advertisement

MED

MED logo

Medifast, Inc.

11.37
USD
Sponsored
+0.54
+4.97%
Feb 06, 16:00 UTC -5
Closed
exchange

After-Market

11.35

-0.02
-0.16%

MED Earnings Reports

Positive Surprise Ratio

MED beat 33 of 40 last estimates.

83%

Next Report

Date of Next Report
Feb 17, 2026
Estimate for Q4 25 (Revenue/ EPS)
$74.54M
/
-$0.82
Implied change from Q3 25 (Revenue/ EPS)
-16.63%
/
+290.48%
Implied change from Q4 24 (Revenue/ EPS)
-37.36%
/
-920.00%

Medifast, Inc. earnings per share and revenue

On Nov 03, 2025, MED reported earnings of -0.21 USD per share (EPS) for Q3 25, beating the estimate of -0.39 USD, resulting in a 46.69% surprise. Revenue reached 89.41 million, compared to an expected 84.94 million, with a 5.26% difference. The market reacted with a +0.84% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 2 analysts forecast an EPS of -0.82 USD, with revenue projected to reach 74.54 million USD, implying an increase of 290.48% EPS, and decrease of -16.63% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
J&J Snack Foods Corp
Report Date
Feb 03, 2026 For Q1 26
Estimate
$0.35
Actual
$0.33
Surprise
-7.30%
logo
John B. Sanfilippo & SON
Report Date
Jan 29, 2026 For Q2 26
Estimate
$1.38
Actual
$1.53
Surprise
+10.45%
logo
Seneca Foods Corp
Report Date
Feb 05, 2026 For Q3 26
Estimate
-
Actual
$6.19
Surprise
-
logo
Mondelez International, Inc. Class A
Report Date
Feb 03, 2026 For Q4 25
Estimate
$0.71
Actual
$0.72
Surprise
+1.28%
logo
Sysco Corporation
Report Date
Jan 27, 2026 For Q2 26
Estimate
$0.98
Actual
$0.99
Surprise
+0.38%
logo
Ingredion Incorporated
Report Date
Feb 03, 2026 For Q4 25
Estimate
$2.66
Actual
$2.52
Surprise
-4.97%
logo
POST HOLDINGS, INC.
Report Date
Feb 05, 2026 For Q1 26
Estimate
$1.72
Actual
$2.13
Surprise
+23.36%
logo
The Marzetti Company Common Stock
Report Date
Feb 03, 2026 For Q2 26
Estimate
$2.26
Actual
$2.20
Surprise
-2.81%
logo
BellRing Brands, Inc.
Report Date
Feb 03, 2026 For Q1 26
Estimate
$0.32
Actual
$0.37
Surprise
+14.55%
FAQ
For Q3 2025, Medifast, Inc. reported EPS of -$0.21, beating estimates by 46.69%, and revenue of $89.41M, 5.26% above expectations.
The stock price moved up 0.84%, changed from $11.88 before the earnings release to $11.98 the day after.
The next earning report is scheduled for Feb 17, 2026.
Based on 2 analysts, Medifast, Inc. is expected to report EPS of -$0.82 and revenue of $74.54M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement